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We studied gene expression pro¢les of 17 cutaneous B
cell lymphomas that were collected with 4^6 mm skin
punch biopsies.We also included tissue from two cases
of mycosis fungoides, three normal skin biopsies, and
three tonsils to create a framework for further interpre-
tation. A hierarchical cluster algorithm was applied for
data analysis. Our results indicate that small amounts of
skin tissue can be used successfully to perform micro-
array analysis and result in distinct gene expression
patterns. Duplicate specimens clustered together
demonstrating a reproducible technique. Within the
cutaneous B cell lymphoma specimens two speci¢c
B cell di¡erentiation stage signatures of germinal center
B cells and plasma cells could be identi¢ed. Primary
cutaneous follicular and primary cutaneous di¡use
large B cell lymphomas had a germinal center B cell
signature, whereas a subset of marginal zone lympho-
mas demonstrated a plasma cell signature. Primary and
secondary follicular B cell lymphoma of the skin were
closely related, despite previously reported genetic
and phenotypic di¡erences. In contrast primary and
secondary cutaneous di¡use large B cell lymphoma
were less related to each other. This pilot study allows
a ¢rst glance into the complex and unique micro-
environment of B cell lymphomas of the skin and
provides a basis for future studies, which may lead to
the identi¢cation of potential histologic and prognostic
markers as well as therapeutic targets. Key words: cuta-
neous B cell lymphoma/di¡use large B cell lymphoma/follicu-
lar lymphoma/marginal zone lymphoma/microarray. J Invest
Dermatol 120:865 ^870, 2003
C
utaneous B cell lymphomas comprise a heteroge-
neous spectrum of disease (Burg et al, 1985). Several
studies have shown that primary cutaneous lympho-
mas behave di¡erently from nodal-based lympho-
mas that involve the skin secondarily (Willemze
et al, 1997;Willemze, 2000). Although the two entities share simi-
lar histologic and immunophenotypic features, as a rule primary
cutaneous B cell lymphomas carries a much better prognosis than
its nodal counterpart and therefore usually requires less aggressive
therapy (Santucci et al, 1991).
At present at least two classi¢cation schemes are in use. One
system was devised by the European Organization for Research
andTreatment of Cancer (EORTC) and pertains only to primary
lymphomas of the skin, whereas the system by theWorld Health
Organization (WHO) was derived from the Revised European-
American Classi¢cation of Lymphoid Neoplasms for hemato-
logic malignancies and covers nodal as well as extranodal
lymphomas (Willemze et al, 1997; Harris et al, 2000). Both
classi¢cation systems take into account a constellation of
morphologic, immunologic, genetic, and clinical criteria.
The EORTC recognizes three prognostic categories of
primary cutaneous lymphomas. In this classi¢cation most of
primary cutaneous B cell lymphomas represent follicle center cell
lymphomas (FCCL) or marginal zone lymphomas (MZL) and
are characterized by an indolent clinical behavior. Primary cuta-
neous FCCL in the EORTC classi¢cation include follicular lym-
phomas (FL) as well as di¡use cutaneous B cell lymphomas of
small cell, mixed, or large cell type. The EORTC excludes only
di¡use large cell lymphomas occurring on the leg from this cate-
gory. This is in contrast to theWHO classi¢cation that separates
follicular center cell derived B cell lymphomas into follicular and
di¡use growth patterns and, furthermore, subclassi¢es the FL ac-
cording to the predominant cell type into grades 1^3. The ratio-
nale to combine FL and di¡use large B cell lymphomas as one
entity by the EORTC was largely based on the observation of
an overall indolent clinical course of these lymphomas, rather
than on the architectural growth pattern, as applied by WHO.
Primary cutaneous di¡use large B cell lymphoma of the leg is a
rare lymphoma that may have a more aggressive clinical behavior
and therefore was classi¢ed separately as intermediate cutaneous
B cell lymphomas in the EORTC system (Willemze et al, 1997;
Grange et al, 2001).
The di¡erent subcategories of lymphoid malignancies are
thought to develop and transform from particular stages of lym-
phocyte di¡erentiation and retain many characteristics of their
normal counterparts (Harris et al, 2001). Lymphomas that corre-
spond to immature and proliferating stages of di¡erentiation
are likely to be aggressive, whereas those that correspond to
naive or mature e¡ector stages are more likely to be indolent.
From genotypic and immunophenotypic data, it has been
proposed that the neoplastic cells in primary cutaneous FCCL
originate from the lymphocytes of the germinal center and
the neoplastic cells in primary cutaneous MZL correspond to
the normal B cells of the marginal zones in the spleen in their
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di¡erentiation (Pandol¢no et al, 2000). For primary cutaneous dif-
fuse large B cell lymphomas the normal counterpart in B cell
lymphocyte ontogeny is postulated to be a germinal center B cell
or a cell at a later stage of di¡erentiation (Pandol¢no et al, 2000).
As a step toward a more complete molecular characterization
of cutaneous B cell lymphomas we used cDNA microarrays with
over 40,000 genes. By analyzing large-scale gene expression pro-
¢les of cutaneous B cell lymphomas we address if genomic
pro¢ling can distinguish between the di¡erent subtypes of cuta-
neous B cell lymphomas and whether distinct gene expression
pro¢les correlate with clinical parameters, outcome data, or cur-
rent classi¢cation systems. The 17 cutaneous B cell lymphoma
samples used in this study were classi¢ed according to theWHO
classi¢cation.
MATERIALS AND METHODS
Patients’ material All frozen tumor tissue was collected in the
Department of Dermatology, Division of Medical Oncology, Stanford
University Medical Center (Stanford, CA, U.S.A.) and archived in the
lymphoma tissue bank in the Department of Pathology, Stanford
University.Table I summarizes the characteristics of patients investigated.
A total of 25 tissue specimens were used in this study, including 17 B cell
lymphoma specimens. Twelve of the 17 cutaneous B cell lymphoma cases
represented primary cutaneous B cell lymphomas with ¢ve FL (including
two tumor biopsies of the same patient), two di¡use large B cell
lymphomas, and ¢ve MZL. The remaining ¢ve cases showed cutaneous
and extracutaneous involvement at presentation and were diagnosed as
three di¡use large B cell lymphomas and two FL.Whereas two of these
¢ve cases clearly represented secondary skin involvement by a lymph
node based lymphoma (FL 98-023b, di¡use large B cell lymphoma
98-007), the remaining three cases (97-022b, 97-022D, 98-020, 98-010b)
may represent an extranodal lymphoma involving the skin secondarily or
a primary cutaneous lymphoma that had disseminated to extranodal sites
prior to diagnosis. We refer to these ¢ve cases as secondary cutane-
ous lymphomas, as all of them had extracutaneous involvement at
presentation.
Additionally, we included two cases of mycosis fungoides (MF), three
normal skin biopsies, and three tonsillectomy specimens. A frozen section
was cut from each specimen prior to RNA isolation to con¢rm that the
archived material was representative of the case. The lymphoma samples
in this study are classi¢ed according to theWHO classi¢cation.
RNA isolation and ampli¢cation Frozen tissue was homogenized
in TRIzol reagent and total RNA was isolated according to the
manufacturer’s instructions (Invitrogen, Life Technologies, Carlsbad, CA).
For most biopsies the total RNA yield was insu⁄cient to meet the
required input of 30^50 mg of total RNA for direct labeling cDNA
microarrays and thus all samples were ampli¢ed. The yield of total RNA
from the lymphoma samples ranged from 20 to 200 mg, and normal skin
yielded 10^20 mg of total RNA. Total RNA samples were cleaned using
the QIAamp RNA Mini Protocol (Qiagen, Valencia, CA) to create a
high-quality template for subsequent RNA ampli¢cation. For
comparative hybridization we used a universal Human Reference RNA
(Stratagene, La Jolla, CA). Two micrograms of total tumor RNA from
each sample and of reference RNAwere subjected to one round of RNA
Ampli¢cation (RiboAmp Kit, Arcturus, Mountain View, CA). The
ampli¢cation process yielded 100^300 x of ampli¢ed anti-sense RNA
(aRNA). For hybridization 3 mg of tumor and reference aRNAwas used.
aRNA labeling and hybridization to spotted cDNAmicroarrays DNA
microarray experiments were done essentially as described previously (Eisen and
Brown,1999).The reverse transcribed reactionwas primed using 9 mg of pd(N)6
random hexamer primer (Amersham Biosciences, Piscataway, NJ). cDNA
probes were labeled using the Cy3 dye (green £uorescent) for the reference
aRNA and the Cy5 dye (red £uorescent) (both Amersham Biosciences) for
each tumor specimen. Each Cy5-labeled experimental cDNA probe was
combined with the Cy3-labeled reference probe and the mixture was
hybridized to spotted cDNA microarrays containing 42,000 spots. cDNA
microarrays were obtained from the core microarray facility at Stanford. All
Table I. Characteristics of patients investigated
CBCL (WHO) Sample Sex Age Site of
biopsy
Extent of skin
involvement
Extracutaneous
involvement
EORTC classi¢cation
FLb 94-001 F 86 Scalp Regional No PCFCCL
FLb 96-002 F 88 Scalp Regional No PCFCCL
FL 99-003 M 38 Scalp Regional No PCFCCL
FL 97-009 M 67 Scalp Regional No PCFCCL
FLa 97-022b/D M 61 Cheek, face Regional Lymph node Not primary cutaneous lymphoma at presentation
FL 98-023b M 34 Forehead, face Generalized Lymph node Not primary cutaneous lymphoma (secondary cutaneous
bone marrow involvement by nodal based lymphoma)
FL 95-025b M 58 Face Generalized No PCFCCL
DLBCLa 89-004b/D M 43 Scalp Regional No PCFCCL
DLBCL 01-012b F 79 Neck Generalized No PCFCCL
DLBCL 98-010b M 50 Arm Generalized Testis Not primary cutaneous lymphoma at presentation
DLBCL 98-007 M 64 Arm Regional LN Not primary cutaneous lymphoma (secondary cutaneous
involvement by nodal based lymphoma)
MZL/DLBCL 98-020 M 73 Flank Generalized Bone marrow Not primary cutaneous lymphoma at presentation
MZL 92-013b M 53 Shoulder Regional No PCIC/PCMZL
MZL 91-015 F 63 Arm Generalized No PCIC/PCMZL
MZL 97-016 F 54 Arm Regional No PCIC/PCMZL
MZL 01-018 M 72 Lateral thigh Generalized No PCIC/PCMZL
MZL 96-005 M 57 Unspeci¢ed Regional No PCIC/PCMZL
MF 01-002b M 75 Forearm Generalized No MF
MF 01-003b M 67 Left £ank Generalized No MF
aDone in duplicates.
bSequential biopsies of the same patient.
CBCL, cutaneous B cell lymphoma; PCFCCL, primary cutaneous follicle center cell lymphoma; DLBCL, di¡use large B cell lymphoma; PCIC, primary cutaneous
immunocytoma; PCMZL According to theWHO classi¢cation for lymphoid tumors, FL is a neoplasm of follicle center B cells/cleaved follicle center cells (FCC) and
centroblast/noncleaved FCC, which has at least a partially follicular pattern. Di¡use large B cell lymphoma is a di¡use proliferation of large neoplastic B lymphoid cells
with nuclear size equal to or exceeding normal macrophage nuclei or more than twice the size of a normal lymphocyte. Extranodal marginal zone B cell lymphoma of
mucosa associated lymphoid tissue (MALT lymphoma, MZL) MALT lymphoma is an extranodal lymphoma compromising morphologically heterogeneous small B cells
including marginal zone cells (centrocyte-like) cells, cells resembling monocytoid cells, small lymphocytes, and scattered immunoblast and centroblast-like cells. There is
a plasma cell di¡erentiation in a proportion of the cases. The in¢ltrate is in the marginal zone of reactive B cell follicles and extends into the interfollicular region.
Additionally, cutaneous B cell lymphomas cases were also diagnosed according to the EORTC classi¢cation for primary cutaneous lymphomas, PCFCCL, primary
cutaneous immunocytoma/MZL (PCIC/primary cutaneous MZL) according to the described standard criteria (Willemze et al, 1997).
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our image ¢les are stored in the Stanford Microarray Database and are accessible
at http://genome-www.stanford.edu/micorarray.
Data analysis The £uorescence ratio for each gene spot on the
hybridized arrays was obtained with a Genepix 4000 scanner (Axon
Instruments, Foster City, CA), and analyzed with Genepix 3.0 software
(Axon Instruments). Uninterpretable spots were manually £agged and
excluded. Hierarchical clustering was performed to analyze the gene
expression data as described previously (Eisen et al, 1998). Genes chosen
for cluster analysis were selected using the following criteria. All
non£agged spots with a £uorescent intensity greater than 1.5 the local
background of the red or green channel were included. Fluorescence
ratios were centered for each gene by subtracting (in log space) the
median ratio observed across all samples. We only included genes that
were at least 3-fold upregulated or downregulated relative to the median
in two arrays and that passed these ¢lter criteria in 80% of the hybridized
arrays.
RESULTS
Overview of the dendrogram We analyzed 25 specimens (19
lymphomas, three normal skin, and three normal tonsil
specimens) using a hierarchical cluster algorithm. This method
arranges the genes and tissue samples according to their degree
of similarity in the pattern of gene expression. The relationships
among the tissue samples are shown here in the form of a
dendrogram where branch lengths re£ect the degree of
similarity between the samples. Very similar tumors are
connected by short branches and longer branches display
diminishing similarity of the tumors. Based on the described
¢ltering criteria in Materials and Methods 1440 unique cDNA
elements were selected that we used for hierarchical clustering.
Figure 1 shows the dendrogram that depicts the degree of
similarity in gene expression among the 25 investigated tissues.
The duplicate experiments (89-004D, 89-004b, 97-022D, 97-
022b) clustered in immediately adjacent columns. The sequential
tumor biopsies of one patient (FL94-001, 96-002) were taken 2 y
apart and did not cluster next to each other but remained within
the same branch. The two MF samples (01-002b, 01-003b)
clustered side by side on the right main branch. Primary and
secondary cutaneous FL were captured on the left main branch.
In contrast primary and secondary cutaneous di¡use large B
cell lymphomas did not cluster together. Whereas the primary
di¡use large B cell lymphomas were found adjacent to primary
and secondary FL, all three secondary di¡use large B cell
lymphomas clustered on the right main branch. Primary
cutaneous MZL ¢gured on both main branches. MZL comprise
a heterogeneous mixture of small lymphocytes, monocytoid B
cells, and plasmacytoid and plasma cells, and usually contain
reactive germinal centers (Cerroni et al, 1997), which may
explain their wide distribution in the cluster. Two of the MZL
showed prominent plasmacytoid di¡erentiation and clustered
closely (91-015, 01-018). Normal skin and tonsil showed a
distinct gene expression signature. Tonsil was found adjacent to
the primary and secondary cutaneous FL and the primary
cutaneous di¡use large B cell lymphomas. Normal skin
clustered on the right branch together with the MF samples and
secondary cutaneous di¡use large B cell lymphomas.
Gene expression patterns in cutaneous B cell lympho-
mas Figure 2(A,B) give an overview of gene expression
pro¢les after hierarchical clustering using 1440 genes. Most
prominent gene clusters seen in Fig 2(A) are genes that are
either upregulated or downregulated in normal skin and normal
tonsil. As this study aims at gaining a ¢rst look at the molecular
level of cutaneous B cell lymphomas, we will focus on the more
subtle gene expression clusters that are associated with distinct
lymphocyte lineage and developmental stages [T cell indicated
in orange (2), GC B cell indicated in blue (1, 3^7, 10), plasma cell
indicated in green (8^9)] and are shown in detail in Fig 2(B).
TheTcell signature was highly expressed in the MF specimens
and variably expressed in the FL and di¡use large B cell
lymphoma. This signature contained components of the T cell
receptor (TCR-a, TCR-b, TCR-g, TCR-d, CD3), T cell surface
markers (CD5, CD6), including downstream signaling proteins
(LAT, ZAP70) (all shown in Fig 2B,T cell 2).
The B cell signature was expressed by the primary and
secondary cutaneous FL and the primary cutaneous di¡use large
B cell lymphomas and comprised antigens associated with the B
cell receptor (CD79a, CD79b, syk, BLNK) (Fig 2B, B cell 4), B
cell speci¢c cell surface markers (CD19, CD20) (Fig 2B, B cell 4),
and transcription factors necessary for certain stages in B cell
development (PAX5, TCL1, Oct-2) (Fig 2B, B cell 4, 7) (Said
et al, 2001; Sha¡er et al, 2001). Furthermore, these tumors,
including the tonsil samples, expressed genes that are known to
be expressed in germinal center B cells [Oct-2, Bob-1, CD21,
BCL-6, ICOS, BLR1 (CXCR5), BCA-1 (CXCL13), RGS13,
BCL7A, BCL11A, LMO2] (Fig 2B, B cell 3^7, 10) (Forster
et al, 1996; Kim et al, 1996; Schubart et al, 1996; Fukuda
et al, 1997; Gunn et al, 1998; Alizadeh et al, 2000; Ansel et al, 2000;
Sha¡er et al, 2001; Tafuri et al, 2001; Reif et al, 2002). BCL-6, as
a characteristic marker of germinal centers, was also upregulated
in normal skin, where it is known to be expressed in
keratinocytes (Yoshida et al, 1996).
Most notably the three secondary di¡use large B cell
lymphoma clustering on the right side of the dendrogram
lacked the above-mentioned germinal center B cell signature
and only shared some genes associated with cell prolifera-
tion (CDC20, thymidine kinase1, cyclin B2, BUB1) (Fig 2B, B
cell 1).
The plasma cell signature could be identi¢ed in two primary
cutaneous MZL with prominent plasmacytoid di¡erentiation
(91^015, 01^018) and in three normal tonsil samples, known to
contain plasma cells. All expressed the recently described
transcription factor XBP-1 (Fig 2B, plasma cell 8), which is
essential for terminal di¡erentiation into a plasma cell (Reimold
et al, 2001). Furthermore, we found that in these two primary
cutaneous MZL with plasmacytic di¡erentiation CD19, CD20,
BCL6, and PAX5 were downregulated. This ¢nding has been
described previously (Calame, 2001) and re£ects the essential
transcriptional events that take place in the transformation and
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Figure1. Overview of dendrogram. A total of 25 lymphoma samples
including normal skin and tonsil were sorted by hierarchical clustering
based on the similarity of gene expression. Patient identi¢cation number,
the year of biopsy and theWHO classi¢cation (blue¼ follicular lymphoma
(FL), red¼ di¡use large B-cell lymphoma (DLBCL), green¼marginal
zone lymphoma (MZL), orange¼mycosis fungoides (MF), black¼ nor-
normal skin, tonsil) are shown directly below the corresponding branch
of the dendrogram. Secondary cutaneous B-cell lymphoma are marked
by’, tumor duplicates by% and the tumor pair by .
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development from a GC B cell to a mature plasma cell. Another
well known cell surface marker of plasma cells Syndecan-1
(CD138) (Fig 2B, plasma cell 9) (Sanderson et al, 1989) was also
expressed in these two MZL. With the exception of these two
MZL with plasmacytoid di¡erentiation, the remaining MZL
showed inconsistent clustering behavior, presumably due to their
heterogeneous lymphoid in¢ltrate. Whereas one case shared the
germinal center B cell gene expression pattern (92^013b), the
rest of the MZL clustered on the right branch with normal skin
and secondary cutaneous di¡use large B cell lymphoma cases.
DISCUSSION
The aim of this study was to contribute to the molecular charac-
terization of cutaneous B cell lymphomas through large-scale
gene expression analysis. Currently, it is not possible to discern
between primary and secondary cutaneous B cell lymphomas
on histopathologic and immunophenotypic examination alone.
Subtle genetic and phenotypic di¡erences have been shown
especially for primary and secondary cutaneous FL.Whereas FL
arising in the lymph node mostly demonstrate the t(14;18) trans-
location, resulting in an overexpression of the anti-apoptotic pro-
tein BCL-2, primary cutaneous FL normally lack both of these
hallmarks (Yunis, 1988; Cerroni et al, 1994, 2000). This ¢nding
provoked several investigators to doubt the existence of a true
primary cutaneous FL (Slater, 1997) and suggested a closer rela-
tionship to MZL (de Leval et al, 2001). Intraclonal diversity of
the immunoglobulin genes in primary cutaneous FCCL indicat-
ing a germinal center cell origin was demonstrated only recently
by using a single cell polymerase chain reaction (Gellrich et al,
2001).
On large-scale expression pro¢ling primary and secondary cu-
taneous FL clustered together in our dataset, showing that these
tumors share an overall common gene expression pattern despite
the known di¡erences. Notably, BCL-2 was not selected with the
criteria used for gene selection. In this study, we chose to use
genes that are either 3-fold upregulated or downregulated relative
to the median across all samples in order to extract meaningful
di¡erentially expressed genes.
Another tumor subtype that clustered with FL consisted of
primary cutaneous di¡use large B cell lymphomas involving the
head area. Despite the di¡erences in histology with a follicular
growth pattern on the one hand and a di¡use pattern on the
other, on the transcriptional level FL and primary cutaneous dif-
fuse large B cell lymphomas appear to be very similar. Their
common signature is characterized by high expression of genes
that de¢ne germinal center B cells and other cells residing in this
special microenvironment, including follicular dendritic cells.
Many of these genes are known to play a crucial part in the for-
mation of the follicular architecture of lymph nodes, Peyer
patches, and the spleen, but so far have not been well described
in skin lymphomas. The overlapping gene expression pro¢les of
FL and primary cutaneous di¡use large B cell lymphomas may
re£ect the gene expression program of the speci¢c di¡erentiation
stage they correspond to. It is important to note that within these
tumor subtypes gene expression was quite heterogeneous and no
single gene was pathognomonic for this group. Nevertheless, the
close relatedness of primary cutaneous FL and di¡use large B cell
lymphomas emerging on the molecular level, provides some sup-
port for the EORTC classi¢cation that groups FL and di¡use
lymphomas in sites other than the leg into one group based on
their overall indolent clinical behavior. An additional interesting
¢nding in FL and primary cutaneous di¡use large B cell lympho-
mas, recon¢rming the rather indolent nature of these entities, was
the lack of gene expression associated with cell proliferation.
Recent gene expression studies in lymph node based lympho-
mas found a virtually unchanged gene expression signature of
GC B cells in FL and some de novo di¡use large B cell lymphomas
(Alizadeh et al, 2000), which is consistent with our data. Further-
more, these large studies identi¢ed at least one new subtype of
di¡use large B cell lymphoma, the activated B like di¡use large
B cell lymphoma, which lacked the GC B cell signature and was
associated with a worse clinical outcome (Alizadeh et al, 2000;
Rosenwald et al, 2002).
The systemic di¡use large B cell lymphomas secondarily in-
volving the skin that were included in our study did not show a
GC B cell signature. According to recent ¢ndings (Alizadeh et al,
2000; Rosenwald et al, 2002), we expected to ¢nd the activated B
like di¡use large B cell lymphoma expression signature in these
three tumors. Surprisingly, this was not the case and we could
only identify a few genes associated with cell proliferation
(CDC20, thymidine kinase 1, cyclin B2) that were shared by
two of these three secondary di¡use large B cell lymphomas
(98^010b, 98^007). But for the most part no common gene ex-
pression signature was evident in these three tumors. This di¡er-
ent ¢nding may be due to the underlying heterogeneity and the
small number of investigated cases in this study. The three cases
consisted of one immunoblastic lymphoma (98^007), one centro-
blastic lymphoma (98^010b) and one lymphoma that represented
large cell transformation of a prior MZL (98^020) and perhaps,
therefore, have failed to show a common expression pattern.
Another interesting ¢nding was the close relatedness of the
one immunoblastic variant of di¡use large B cell lymphoma
(98^007) with the plasmacytoid MZL. It is known that upon
antigen encounter, mature nave B cells appear to move into the
T cell zone of lymphoid tissues, where they transform into large
B blasts and then proliferate and di¡erentiate into short-lived,
IgM-producing plasma cells or into B cells that acquire the capa-
city to initiate a germinal center reaction (McHeyzer-Williams
et al, 2001). The overlapping global gene expression pro¢le found
in one immunoblastic di¡use large B cell lymphoma and two
plasmacytic MZL may re£ect the similarities of gene expression
repertoires in these entities.
Whereas primary cutaneous MZLwith plasmacytic di¡erentia-
tion showed a plasma cell signature and clustered closely, primary
cutaneous MZL with no plasmacytic di¡erentiation showed in-
consistent clustering behavior, which most likely is due to their
heterogeneous composition. The plasma cell fate has been shown
to be associated with a loss of molecules (CD19, CD20, BCL-6,
Pax5), which are essential for the GC B cell, and a gain of mole-
cules (XBP-1, CD138), which are needed for the plasma cell func-
tion (Calame, 2001) and can be observed in our result. MZL
contain reactive as well as colonized follicles that may in£u-
ence their cluster behavior toward germinal center derived
lymphomas.
In summary, we have shown that microarray analysis can be
performed successfully using a small amount of skin tissue as
starting material. We have gained a ¢rst insight into the specia-
lized microenvironment of the most common subtypes of cuta-
neous B cell lymphomas and have set the starting point for a
larger and more elaborate study that will also include primary

Figure 2. Cluster Analysis. (A) Overview of the hierarchical clustering (average linkage) of 1440 genes selected from 25 lymphoma samples including
normal skin and tonsil. Each row represents a separate cDNA clone on the microarray and each column a separate tissue sample. Red, green and black
squares indicate that expression of the gene is greater, less than or equal to the median level of expression acrossall 25 tissues, respectively. Gray represents
missing or poor quality data.The scale bare re£ects the fold increase (red) or decrease (green) for any given gene relative to median level of expression across
all samples. (B) Lineage and stage speci¢c signatures could be identi¢ed. The blue bar indicates gene clusters associated with the B-cell receptor, B-cell
surface markers, transcription factors and genes associated with germinal centers. The orange bar depicts genes associated with the T-cell receptor, T-cell
surface markers and signaling molecules. The green bar shows genes particularly expressed in plasma cells. Numbers 1-10 indicate each speci¢c gene cluster
and corresponding position in the cluster overview.
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cutaneous di¡use large B cell lymphomas of the leg. The speci¢c
gene expression signatures found in FL and primary cutaneous
di¡use large B cell lymphomas, not involving the leg, give
further support for a GC origin of these entities, which was
shown previously (Kerl and Kresbach, 1984; Gellrich et al, 2001)
and may explain the overall favorable prognosis of these patients.
A larger set of tumor samples may help to identify single or mul-
tiple genes, which will be of diagnostic, prognostic, and thera-
peutic value, and will intensify our understanding of the diverse
biology of these tumors. Potential candidate genes could further-
more be quantitated using real-time PCR as shown previously
(Korz et al, 2002).
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